Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the sale, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. The trade was a 33.66 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Trupanion Stock Up 2.7 %
TRUP opened at $34.09 on Thursday. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The business’s 50-day moving average price is $43.21 and its 200-day moving average price is $47.24. The company has a market cap of $1.45 billion, a P/E ratio of -148.22, a P/E/G ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. On average, equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
A number of brokerages recently weighed in on TRUP. Piper Sandler decreased their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $46.60.
Get Our Latest Analysis on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- NYSE Stocks Give Investors a Variety of Quality Options
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Best Aerospace Stocks Investing
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.